Healthcare teams should treat API visibility as a control, not a documentation exercise. Start by building a complete inventory of internal, external, and third-party APIs, then map ownership, authentication method, data sensitivity, and business purpose. Without that baseline, security teams cannot test, monitor, or revoke access consistently, and hidden endpoints become easy entry points for attackers.
Why API visibility has to come before more patient-facing connections
Healthcare organisations often want to expand digital access quickly, but API expansion without visibility creates a blind spot around who can call what, which data is exposed, and which services can still be reached after a change. That matters because patient-facing integrations usually touch protected health information, clinical workflows, and identity-bound access paths. A security team that cannot identify the full API surface cannot reliably test controls, detect drift, or prove that an endpoint is still needed. For broader control context, NIST SP 800-53 Rev 5 Security and Privacy Controls gives a useful baseline for access, monitoring, and configuration governance. In practice, many healthcare teams discover unmanaged APIs only after a partner integration, mobile release, or legacy service has already exposed more data than the original design intended.
What effective API visibility looks like in a healthcare environment
Good API visibility is not just a list of endpoints. It is a working control plane for discovery, ownership, risk classification, and change management. Security teams need to know whether an API is internal, partner-facing, or public; whether it is serving patients, providers, billing, or devices; and what data types it can return or modify. That inventory should include versioning, authentication type, authorization scope, and any dependency on third-party middleware or identity providers. If an API cannot be tied to a clear owner, it should be treated as a governance gap until someone accepts accountability.
In practice, teams usually need to combine multiple sources of evidence: gateway logs, service catalog records, cloud configuration, CI/CD pipelines, and traffic observation. That is important because documentation alone often lags behind deployed reality. Visibility should also distinguish between exposed endpoints and actually used endpoints. An endpoint may be technically live but unused, or heavily used but never formally approved. Both conditions are relevant, but they lead to different actions.
- Inventory APIs by environment, owner, and external exposure.
- Classify each API by data sensitivity and business purpose.
- Record the authentication and authorization model for every endpoint.
- Track version, lifecycle status, and retirement date where possible.
- Confirm where logging, rate limiting, and anomaly detection actually exist.
For healthcare teams, this visibility also needs to account for patient access patterns, vendor mediation, and downstream system effects. If one integration fans out into multiple services, the visible API may not be the only asset at risk. The guidance breaks down when inventories are treated as static documents instead of continuously updated operational records.
Where healthcare API visibility becomes harder, and what teams should watch
Tighter API control often increases operational overhead, requiring organisations to balance faster digital rollout against stronger governance of exposed services. That tradeoff becomes most obvious in hybrid estates, acquired systems, and partner ecosystems where the same data may flow through several interfaces before reaching the patient.
One common edge case is shadow APIs created by development teams that bypass the main gateway during testing and later remain reachable in production. Another is a vendor-managed integration where the healthcare organisation owns the data risk but does not directly administer the interface. Guidance on whether to block, restrict, or retire an API is sometimes straightforward, but consensus is weaker when the endpoint supports legacy clinical workflows and cannot be removed quickly without care disruption. In those cases, teams should separate temporary exception handling from long-term acceptance. Visibility should also extend to machine-to-machine access, because patient-facing services often rely on backend tokens, service accounts, or certificates that outlive the original deployment decision. If those dependencies are not visible, they can outlast the controls that were supposed to govern them.
Risk and Threat Considerations
API sprawl in healthcare creates exposure through unknown attack surface, overbroad data access, and weak lifecycle control. The risk is not limited to public endpoints; internal and partner APIs can also leak data or permit unauthorized actions when ownership, authentication, and monitoring are unclear.
Failure mechanism: Attackers and abusive insiders often exploit forgotten endpoints, misconfigured authorization, or stale credentials that still reach live services. When teams lack inventory and ownership, they also lose the ability to revoke access cleanly after a compromise or integration change.
Impact: The result can be protected health information exposure, account takeover of integration paths, manipulation of patient records, and prolonged undetected access across connected systems.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
OWASP Non-Human Identity Top 10 address the attack and risk surface, while CIS Controls v8 and NIST CSF 2.0 set the governance and control requirements practitioners need to meet.
| Framework | Control / Reference | Relevance |
|---|---|---|
| CIS Controls v8 | CIS 1 — Inventory and Control of Enterprise Assets | API discovery and ownership mapping are asset inventory problems. |
| Recommendation — Inventory every exposed API and tie each one to an accountable owner. | ||
| NIST CSF 2.0 | ID.AM-1 — Physical devices and systems within the organization are inventoried | API visibility depends on complete discovery of the service surface. |
| PR.AC-1 — Identities and credentials are issued, managed, verified, revoked, and audited | API visibility must include how each endpoint authenticates and is revoked. | |
| DE.CM-1 — The network is monitored to detect potential cybersecurity events | Traffic monitoring is needed to find hidden or shadow APIs. | |
| Recommendation — Maintain a live inventory of APIs before exposing new patient integrations. Map and govern API credentials so access can be revoked consistently. Monitor API traffic to surface undocumented or stale endpoints. | ||
| OWASP Non-Human Identity Top 10 | NHI-01 — Secrets and Credential Management | Patient-facing APIs commonly rely on service credentials and tokens. |
| Recommendation — Track and rotate API secrets so hidden access paths do not persist. | ||
Practitioner Guidance
What to prioritise: Start with the APIs that can reach patient data, authentication flows, or write actions. Those paths create the highest consequence if they are undocumented or poorly governed, and they are usually the fastest way to reduce real exposure.
What to verify: Confirm that every live API has an owner, a purpose, a data classification, and a current access path. If any one of those is missing, the team should treat the API as operationally visible but not yet governable.
What good looks like: A healthcare team should be able to answer, without searching multiple systems, which APIs are externally reachable, which are patient-facing, which are third-party mediated, and which can be safely retired. That is the practical test of visibility, not the existence of a catalogue.
Practitioner takeaway: Visibility only matters when it changes the team’s ability to test, restrict, and remove access before the next integration goes live.
Related resources from NHI Mgmt Group
- How should security teams assess API ecosystem maturity before expanding integrations and automation?
- How should security teams implement identity visibility before tightening access controls?
- How should healthcare security teams manage expanding API and web application attack surfaces?
- How should security teams implement API security testing across distributed services and partner integrations?
Deepen Your Knowledge
Reviewed and updated by the NHIMG editorial team on September 8, 2026.
NHI Mgmt Group — the #1 independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org